SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Concerns about Chinese memory maker CXMTs progress on a denser DRAM design are weighing on Micron and other memory stocks, alongside broader semiconductor weakness. Traders debate whether the technology poses a meaningful future threat or is years from competing at scale, while bullish voices point to Microns AI-memory demand and fundamentals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is being swept up in a semiconductor and memory-stock selloff as traders react to Chinas CXMT memory-design progress and concerns about the funding and returns on AI infrastructure spending. The community is divided between seeing an overreactionsome note CXMTs announcement concerns DRAM while SanDisk primarily sells NANDand fearing stronger competition, oversupply, and a slowdown in AI demand.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Weakness in semiconductor and memory stocks, amid concerns about Chinese chip competition, is weighing on QQQ. Traders are split between viewing the tech-led pullback as the start of a deeper correction and seeing it as a buyable dip, with inflation data and bank earnings adding uncertainty.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention amid a sharp semiconductor-sector pullback, with traders linking the weakness to concerns about AI spending and demand, alongside heavy selling in memory-chip stocks. The community is divided between buyers calling the drop an overreaction and bearish traders warning that momentum remains weak and the leveraged ETF can amplify losses.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

Deutsche Banks Buy upgrade is supporting a rebound after the selloff sparked by SpaceXs spectrum deal, while BlueBirds 1416 reaching Florida adds progress on satellite deployment. Bulls argue SpaceXs push into mobile could strengthen ASTSs role with established carriers; bears remain focused on launch delays, execution and competition.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAIs latest AI workload is running on Nvidia GPUs rather than Cerebras hardware have fueled concern about Cerebras reliance on OpenAI and pressured the shares. Traders also cite upcoming share unlocks as a potential source of selling, while bulls view the decline as a buying opportunity and bears warn of further downside.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broader selloff in AI and neocloud stocks, with traders focused on a report that OpenAIs annualized revenue was below previously circulated estimates and growing concerns about AI infrastructure spending, debt, and valuations. Some see the reaction as an overblown response to differing revenue-accounting methods and remain bullish on Nebiuss customer demand, while others fear the sectors momentum is fading.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel shares are caught in a broader semiconductor selloff as traders weigh concerns about the cost and returns of AI infrastructure spending, alongside worries about AI revenue expectations. The steep decline has prompted frustration and bearish talk about a breakdown, while other traders view the pullback as oversold and are watching the $100 area for support.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is under pressure amid concern that Chinas CXMT is advancing denser DRAM technology and could become a future competitor in server memory. Traders disagree on the significance: some fear added supply and competition, while others argue CXMTs claims remain unproven and commercial impact is distant; weakness in Korean markets is also weighing on sentiment.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

A sharp selloff in South Koreas KOSPI is driving attention to KORU, with traders noting that the funds 3 leverage magnifies the indexs decline. Some attribute pressure on Korean chip stocks to concerns about Chinese memory competition, while others are buying the dip or looking to short further weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $510.08, marking a +1.36% move from the previous day.

Vertex to Present New Data on ALYFTREK at the North American Cystic Fibrosis Conference

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children...

If You Invested $100 In Vertex Pharmaceuticals Stock 5 Years Ago, You Would Have This Much Today

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 5 years by 10.96% on an annualized basis producing an average annual return of 23.3%. Currently, Vertex Pharmaceuticals has a marketread more...

Vertex to Announce Third Quarter 2026 Financial Results November 2nd

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its third quarter 2026 financial results on Monday, November 2, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (833) 630-2124 (U.S.) or +1...

Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?

Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know  

Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Amgen vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Key PointsAmgen offers a diversified portfolio of established therapies across oncology and inflammation supported by robust cash flow...

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $506.74, marking a -3.07% move from the previous day.

Axsome Therapeutics vs. Vertex Pharmaceuticals: Which Biotech Stock Is a Better Buy in 2026?

Key PointsAxsome Therapeutics is delivering explosive revenue growth as it scales its commercial portfolio for central nervous system disorders...

2 Wall Street Analysts Think Vertex Pharmaceuticals Stock Can Soar Another 20% or More Over the Next 12 Months. Here's Why They're Right.

Key PointsVertex Pharmaceuticals is the leader in the cystic fibrosis market and has the intellectual property to maintain this dominance...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Current Price	$507.00
Prev Close	$510.08
Open	$512.44
Dividend Yield	0.00%
50-Day Moving Average	$521.06
Beta	0.53
Avg. Volume	1.02M
PE Ratio	29.50

52-Week High	$560.25
52-Week Low	$403.16
Market Capitalization	$129.29B
EPS (Annual)	$15.32
Price to Book	6.34
Revenue Per Employee	$1.89M

Feed

News

Sentiment

Earnings

Fundamentals

Info

VRTX Fundamentals